AU Stock MarketDetailed Quotes

SNT Syntara Ltd

Watchlist
  • 0.067
  • 0.0000.00%
20min DelayMarket Closed Dec 9 16:00 AET
92.00MMarket Cap-4187P/E (Static)

About Syntara Ltd Company

Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring, and neuroinflammation.

Company Profile

SymbolSNT
Company NameSyntara Ltd
Founded1998
MarketASX
Employees21
Fiscal Year Ends06-30
Address20 Rodborough Road Unit 2
CitySydney
CountryAustralia
Zip Code2086
Phone+61 287601480
Share RegistryBOARDROOM PTY LIMITED LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000 (02) 9290 9600

Company Executives

  • Name
  • Position
  • Salary
  • Gary Jonathan Phillips
  • Executive Director and Chief Executive Officer
  • --
  • Jana Baskar
  • Chief Medical Officer
  • --
  • David Morris McGarvey
  • Chief Financial Officer and Company Secretary
  • --
  • Kathleen Mary Metters
  • Non-Executive Chairman of the Board
  • --
  • Simon Green
  • Director
  • --
  • Hashan De Silva
  • Director
  • --
Heat List
AU
Overall
Symbol
Price
% Chg

No Data